All Human Genome Sciences articles
-
Business
GSK secures $3.6bn HGS deal
GlaxoSmithKline is set to buy Human Genome Sciences for $3.6 billion
2012-07-20T00:00:00Z
GlaxoSmithKline is set to buy Human Genome Sciences for $3.6 billion
Site powered by Webvision Cloud